Logo image
Differences in metabolism of the marine biotoxin okadaic acid by human and rat cytochrome P450 monooxygenases
Journal article   Peer reviewed

Differences in metabolism of the marine biotoxin okadaic acid by human and rat cytochrome P450 monooxygenases

Franziska Kolrep, Stefanie Hessel, Anja These, Anke Ehlers, Kathleen Rein and Alfonso Lampen
Archives of toxicology, Vol.90(8), pp.2025-2036
08-01-2016
PMID: 26374342

Abstract

Animals Cell Culture Techniques Cell Survival - drug effects Chromatography, High Pressure Liquid Cytochrome P-450 CYP1A2 - genetics Cytochrome P-450 CYP1A2 - metabolism Cytochrome P-450 CYP3A - genetics Cytochrome P-450 CYP3A - metabolism Hep G2 Cells Humans Liver - drug effects Liver - enzymology Marine Toxins - toxicity Okadaic Acid - toxicity Rats Recombinant Proteins - genetics Recombinant Proteins - metabolism Species Specificity Tandem Mass Spectrometry
The ingestion of seafood contaminated with the marine biotoxin okadaic acid (OA) can lead to diarrhetic shellfish poisoning with symptoms like nausea, vomiting and abdominal cramps. Both rat and the human hepatic cytochrome P450 monooxygenases (CYP) metabolize OA. However, liver cell toxicity of metabolized OA is mainly unclear. The aim of our study was to detect the cellular effects in HepG2 cells exposed to OA in the presence of recombinant CYP enzymes of both rat and human for the investigation of species differences. The results should be set in correlation with a CYP-specific metabolite pattern. Comparative metabolite profiles of OA after incubation in rat and human recombinant CYP enzymes were established by using LC-MS/MS technique. Results demonstrated that metabolism of OA to oxygenated metabolites correlates with detoxification which was mainly catalyzed by human CYP3A4 and CYP3A5. Detoxification by rat Cyp3a1 was lower compared to human CYP3A enzymes and activation of OA by Cyp3a2 was observed, coincident with minor overall conversion capacity of OA. By contrast human and rat CYP1A2 seem to activate OA into cytotoxic intermediates. In conclusion, different mechanisms of OA metabolism may occur in the liver. At low OA doses, the human liver is likely well protected against cytotoxic OA, but for high shellfish consumers a potential risk cannot be excluded.

Metrics

Details

Logo image